Photokinetic Drug Delivery: Light-Enhanced Permeation in an In Vitro Eye Model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Photokinetic Drug Delivery: Light-Enhanced Permeation in an In Vitro Eye Model

Published:2015-12 Issue:10 Volume:31 Page:650-657
ISSN:1080-7683
Container-title:Journal of Ocular Pharmacology and Therapeutics
language:en
Short-container-title:Journal of Ocular Pharmacology and Therapeutics

Author:

Godley Bernard F.¹,Kraft Edward R.¹,Giannos Steven A.¹,Zhao Zhen-Yang¹,Haag Anthony M.²,Wen Julie W.³

Affiliation:

1. Department of Ophthalmology and Visual Sciences, University of Texas Medical Branch, Galveston, Texas.

2. Biomolecular Resource Facility, University of Texas Medical Branch, Galveston, Texas.

3. Electron Microscopy Laboratory, University of Texas Medical Branch, Galveston, Texas.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmacology,Ophthalmology

Link

http://www.liebertpub.com/doi/pdf/10.1089/jop.2015.0005

Reference35 articles.

1. 2002 Global update of available data on visual impairment: a compilation of population-based prevalence studies

2. Causes and Prevalence of Visual Impairment Among Adults in the UnitedStates

3. Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study

4. Barrier Modulation in Drug Delivery to the Retina

5. Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Topical Solution for Retinal Delivery: Bevacizumab and Ranibizumab Eye Drops in Anti-Aggregation Formula (AAF) in Rabbits;Pharmaceutical Research;2024-06

2. Photokinetic Drug Delivery: Near infrared (NIR) Induced Permeation Enhancement of Bevacizumab, Ranibizumab and Aflibercept through Human Sclera;Pharmaceutical Research;2018-03-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3